Abstract
Background: Substantial investment in malaria control worldwide has led to dramatic declines in transmission since 2000. However, progress has stalled, and in settings where funding for malaria control has been withdrawn, malaria has been resurgent. Therefore, we aimed to assess the effect of the Project for Malaria Control in Andean Border Areas (PAMAFRO) on malaria incidence across the Loreto region of Peru. Methods: We conducted a retrospective, observational, spatial interrupted time series analysis of malaria incidence among people reporting to health posts across the Loreto region of Peru between January 2000 and December 2011. We used information on the number of diagnosed cases of Plasmodium vivax and Plasmodium falciparum, as determined by microscopy. We also used data on environmental variables associated with malaria transmission, including temperature, precipitation, soil moisture, soil temperature, and windspeed, which were derived from a Land Data Assimilation System designed for the Amazon region. We used census data to define the population at risk. We used Bayesian spatio-temporal modeling techniques to estimate the impact of the PAMAFRO program. Findings: During the PAMAFRO program, incidence of P. vivax declined from 42.8 cases/1,000 people/year to 10.1 cases/1,000 people/year. Incidence for P. falciparum declined from 14.3 to 2.5 cases/1,000 people/year over this same period. The effects of PAMAFRO-supported interventions varied both by geography and species of malaria. Interpretation: The PAMAFRO program was wildly successful, but reductions in transmission were not sustained after the program ended. Malaria control programs must ensure continued financing of malaria control programs to sustain reductions in transmission. Funding: National Aeronautics and Space Administration, and the National Institutes of Health Declaration of Interest: We declare no conflicts of interest Ethical Approval: This study analyzes publicly-available, de-identified, secondary data, and therefore did not require ethics approval
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
